ÂÜÀòÂÒÂ×

Stephen Covel CPA, MBA, has extensive experience in finance and operations within the biotechnology sector, currently serving as Vice President and Head of Finance and Operations for Biogen Intercontinental and Biosimilars Business since 2010. In this role, Stephen drives financial planning and analysis for a P&L exceeding $1 billion. Previously, Stephen has held key positions including Chief Audit Executive at Biogen, where leadership was provided to a global internal audit team, and Senior Director of Finance for Pharmaceutical Operations & Technology, overseeing annual operating plans and capital investments. Early career experience included a Senior Manager role at Deloitte, focusing on business risk consulting and Sarbanes-Oxley compliance for Fortune 500 companies. Stephen holds an MBA from Babson F.W. Olin Graduate School of Business and a B.S. in Accounting from Syracuse University.